Minister Butler's press conference in Adelaide on June 1, 2026, focused on the government's commitment to making medicines more affordable and accessible for Australians, particularly in the context of the Pharmaceutical Benefits Scheme (PBS). The conference highlighted the listing of two new treatments for blood cancer, Blincyto and Calquence, which will be available at affordable PBS prices, benefiting approximately 110 and 1,200 patients annually, respectively. These treatments represent a significant advancement in the fight against blood cancer, offering improved survival rates and quality of life for patients.
Dr. Uwe Hahn, a haematologist at the Royal Adelaide Hospital, emphasized the effectiveness and safety of Calquence, which is administered in tablet form, allowing patients to spend more time at home and reducing hospital stays. Alona Robinson, a patient who participated in the clinical trial for Calquence, shared her positive experience and the life-changing impact of the treatment, expressing gratitude for the opportunity to access it through the PBS.
Minister Butler acknowledged the rapid pace of medical discoveries and the challenges of managing the increasing number of applications for new listings on the PBS. He attributed this to technological advancements, such as big data and artificial intelligence, which are accelerating the development and availability of new therapies. The government's focus on affordable healthcare, including cheaper medicines and increased free doctor visits, aims to alleviate the financial burden on households and promote the health of the nation.
Despite the positive announcements, the conference also touched on the government's response to the Ebola outbreak in the Democratic Republic of Congo and the impact of the war in Iran on the economy. Minister Butler emphasized the importance of containment measures and the need for regular advice from health authorities. Additionally, he addressed the recent polling data showing One Nation ahead of Labor, attributing it to the economic pressures faced by households and the government's efforts to provide cost-of-living relief.
In conclusion, the press conference highlighted the government's commitment to improving healthcare access and affordability, while also addressing the challenges posed by global events and economic pressures. The listing of new cancer treatments and the government's response to the Ebola outbreak demonstrate the government's proactive approach to public health and safety.
